Council for Tobacco Research
1979 Report of the Council for Tobacco Research - U.S.A, Inc. [St]
Fields
- Depository Date
- 25 Sep 1995
- Master ID
- Ctrmn00010849-2859
Related Documents:- CTRMN010849-0887 Deposition of Lorraine Pollice [Deposition of Pollice in the Matter of Allgood]
- CTRMN010888-0889 Scientific Advisory Board Members 1954- [Record of Names of Members]
- CTRMN010890-0892 Curriculum Vitae [St]
- CTRMN010893-0919 Curriculum Vitae [St]
- CTRMN010920-0926 [St]
- CTRMN010927-0938 Curriculum Vitae [St]
- CTRMN010939-0956 Curriculum Vitae [St]
- CTRMN010957-0958 Curriculum Vitae of Dr. Mckeen Cattell [St]
- CTRMN010959-0960 Curriculum Vitae of Dr. Julius E. Comroe Jr. [St]
- CTRMN010961-0974 Curriculum Vitae [St]
- CTRMN010975-0990 Abstracts [St]
- CTRMN010991-1010 [St]
- CTRMN011011-1020 Curriculum Vitae [St]
- CTRMN011021-1056 Curriculum Vitae [St]
- CTRMN011057-1082 Jeffrey Robert Idle Curriculum Vitae [St]
- CTRMN011083-1092 Leon Orris Jacobson, M.D. [St]
- CTRMN011093-1116 Curriculum Vitae [St]
- CTRMN011117-1123 Curriculum Vitae [St]
- CTRMN011124-1126 Curriculum Vitae of Dr. Paul Kotin [St]
- CTRMN011127-1128 Curriculum Vitae of Dr. Clarence Cook Little [St]
- CTRMN011129-1132 Biographical Sketch [St]
- CTRMN011133-1160 Curriculum Vitae [St]
- CTRMN011161-1161 Ctr Mn 011161 Is Unused [Record of Bates Number]
- CTRMN011162-1163 Curriculum Vitae of Dr. Kenneth Merrill Lynch [St]
- CTRMN011164-1166 Curriculum Vitae [St]
- CTRMN011167-1176 Curriculum Vitae Gordon Barry Pierce, Jr., M.D. [St]
- CTRMN011177-1178 Curriculum Vitae of Dr. Stanely Philip Reimann [St]
- CTRMN011179-1180 Curriculum Vitae of Dr. William Francis Rienhoff Jr. [St]
- CTRMN011181-1190 Curriculum Vitae of Gordon Sato [St]
- CTRMN011191-1219 Curriculum Vitae [St]
- CTRMN011220-1239 Curriculum Vitae [St]
- CTRMN011240-1241 Biographical Sketch [St]
- CTRMN011242-1243 Curriculum Vitae of Dr. Edwin Bidwell Wilson [St]
- CTRMN011244-1245 Curriculum Vitae [St]
- CTRMN011246-1274 1956 Report of the Scientific Director [St]
- CTRMN011275-1325 Report of the Scientific Director [St]
- CTRMN011326-1359 1958 Report of the Scientific Director [St]
- CTRMN011360-1396 1959 Report of the Scientific Director [St]
- CTRMN011397-1430 1960 Report of the Scientific Director [St]
- CTRMN011431-1467 1961 Report of the Scientific Director [St]
- CTRMN011468-1499 1962 Report of the Scientific Director [St]
- CTRMN011500-1500 Ctr Mn 011500 Is Unused [Record of Bates Number]
- CTRMN011501-1535 Annual Report of the Scientific Director [St]
- CTRMN011536-1576 Report of the Scientific Director [St]
- CTRMN011577-1619 Report of the Scientific Director [St]
- CTRMN011620-1662 Annual Report of the Scientific Director [St]
- CTRMN011663-1720 Annual Report of the Scientific Director [St]
- CTRMN011721-1765 Report of the Scientific Director [St]
- CTRMN011766-1815 Annual Report of the Council for Tobacco Research U.S.A, Inc. [St]
- CTRMN011816-1870 Report of the Council for Tobacco Research - U.S.A., Inc. 1972 [St]
- CTRMN011871-1871 Ctr Mn 011871 Is Unused [Record of Bates Number]
- CTRMN011872-1921 Report of the Council for Tobacco Research - U.S.A., Inc. [St]
- CTRMN011922-1968 Report of the Council for Tobacco Research, U.S.A., Inc. [St]
- CTRMN011969-2011 1975 Report of the Council for Tobacco Research - U.S.A., Inc. [St]
- CTRMN012012-2057 1976 Report of the Council for Tobacco Research - U.S.A., Inc. [St]
- CTRMN012058-2101 1977 Report of the Council for Tobacco Research - U.S.A., Inc. [St]
- CTRMN012102-2156 Report of the Council for Tobacco Research, U.S.A., Inc. [St]
- CTRMN012211-2211 Ctr Mn 012211 Is Unused [Record of Bates Number]
- CTRMN012212-2268 1980 Report of the Council for Tobacco Research - U.S.A, Inc. [St]
- CTRMN012269-2329 Report of the Council for Tobacco Research - U.S.A., Inc. [St]
- CTRMN012330-2386 1982 Report of the Council for Tobacco Research - U.S.A., Inc. [St]
- CTRMN012387-2458 1983 Report of the Council for Tobacco Research - U.S.A., Inc. [St]
- CTRMN012459-2533 1984 Report of the Council for Tobacco Research - U.S.A., Inc. [St]
- CTRMN012534-2534 Ctr Mn 012534 Is Unused [Record of Bates Number]
- CTRMN012535-2647 1985 Report of the Council for Tobacco Research - U.S.A., Inc. [St]
- CTRMN012648-2744 1986 Report of the Council for Tobacco Research - U.S.A., Inc. [St]
- CTRMN012745-2844 1987 Report of the Council for Tobacco Research - U.S.A., Inc. [St]
- CTRMN012845-2859 Partial Listing of Research Institutions, Ctr Grantees at Those Institutions, and Dates the Grantee Received Ctr Funding at That Institution [St]
- Author
- Ctr
- Request
- 118
- Type
- ANNUAL REPORT
- Box
- 006
- UCSF Legacy ID
- pvr30a00
Document Images
ANDREWS OFFICE PRODUCTS CAPITOL HEIGHTS, MD (K)

1979 REPORT
o/
THE COUNCO. FO7t TOBACCO RF.SEARCH-U.9.A., I.e.
TEE COUN(71. FOR T()BA(:CO RE3EAR(71-11.9.A., lat.
l 10 F...1 59t6 3eree1, New Y.ric, N.Y. 10022

SCIFIV'17FIC ADVISORY BOARD
to The Council for Tobacco Re.aucb-U.S.A., Inc.
as ot December 31. 1979
SHFII)ON C. SOMMERS, M.D., Cho"sr
Dlrenor of Laboratorle.r, Ltaos Hill Hospital
Cpnkd Pro/estor of Pathology
Colkge of Ph)sician. t Surteoas of Columbia University
New Yort, New York
RICHARD J. BtNO, M.D.
Dlrertor of Crdlolosy and Introrwao/ Afedklne
Huntington Memorial Ho.pital, Paadeea, Catitorda
Professor of Medklne
Unlrenity of Soutl+er. CalYornia Scbool of Medicine
[.o. AngeJea, California
JOSFPII D. FELDMAN. M.D.
Head, Department of leununopatbolop
Seripp C1mie and Research Foundation
La 1 _olla, Cati(ornia
iVQ.UAM U. GARDNER. Pn.D.
Sdent!/ic Dirertor, The Council for Tobacco Research-U.S.A., Inc.
E.1C. Hrnt ProJcsavr of Anaton+y (en.rritut)
Yab Unireniq School of Medicine
New Haren, Conoecticut
ROBERT J. HUEBNER, M.D.
Chfe/, laboratory of RNA Tumor Vinues
National Cancerr Institute
Betbe.d., Maryland
LFrON O. JACOBSON, M.D.
loseph Retentteln Professor of Biological Scknres
icago
Cbkambiooi.
HENRY T. LYNCH, M.D.
Professor and ClwJrnwn
Department of Preventive Medicine and Public Heatth
Crel~too Uoivenity School of Medicine
Om a, Nebraaka
HANS MEIER, D.V.M.. Dr. Med. Vet., M.R.S.H.
Senior StaO Scknttrt
Tbe Jackson IAboratory
Bar Harbor, Maloe
JOHN P. WYATT, MD.
Tlrector
obaoco and Health Research Institute
University of Kentucky
Les)nSton, KeatucJ:y
9eleetlfe Staa./ T`. Cw.dl
WILLJAM U. OARDNP.R, Pa.D.
Scientific Dbrelw
ROBERT C. HOCKE7T, Pe.D.
Research Director
DONALD H. FORD, Ptt.D. VINCF.NT F. USANT4. D.MD.
Associate Research Director Assodate Reserc h Director
DAVID SfONB, Pa.D.
As.ociate ResrrdY DLMctor

CONTENTS
Introduction . . . . . . . . . . . . . . . . . . 7
Abatracta of Reporta . . . . . . . . . . . . . . . . 9
Caocer-Related Studies . . . . . . . . . . . . . 9
The Respiratory System . . . . . . . . . . . . 22
1leart and Circulation . . . . . . . . . . . . . 32
Neuropharmaoolop and Phrtiobp . . . . . . . . . 39
Pharmacology .ed BiothemLtry . . . . . . . . . . 49
Immunology and Adaptive Mechanisms . . . . . . . 67
Epidemioio8,y . . . . . . . . . . . . . . . . 78
Active Projects . . . . . . . . . . . . . . . . . . 83
Completed Projects . . . . . . . . . . . . . . . . 92
Itsde: of Priscip.l Investigators . . . . . . . . . . . . !03
Index of Scnior Authors . . . . . . . . . . . . . . 104
i
I
/
JOHN P. WYA7T
n 916.1980
lohn P. Wyatt, a member of the SckntiAc Advisory Board for aeven
years. died January 22. A distinguished pathologist and specialist in pul-
monary disorders, he had heew, sinoe 1974. Director of the Tobacco
and Health Research Institute at the Univasity of Leaington. Kentucky.
Before that he was Professor and Head of the Department of Pathology
.t the University of Manitoba Faculty of Medicine, Winnipeg, Canada.
lack Wyatt was a modern version of the Renaissance man, aervin8.ocieq
well as a physician and researcher at the same lime that he explored (or
truths in literature and the arts. He frequently enlivened Advisory Board
meetinp with quotationf from literary {re.u that struck directly to the
core of the matter under discussion. Articulate, witty, gregarious. ).ct
Wyatt dwars sought to Improve the Imperfect world of scknoe. He took
panicui.rly to bean his responsibiliy as a member of tha Scknti6e Ad-
visory Board and arove in thN body, in his owo institution and el.ewhert,
to advance acieati/k knowledge and better the human conditloa !1e wiY
be deeply missed.

Introduction
The Council /or Tobacco Research continued ouriaQ 1979 to pravide L
oancial support (or independent scientists who are aeeking to add to knowledr
of canur, cardiovascular diseases and chronic pulmoaary ai4nema.
The tact is that the etiology of ttrese map' ~ailmenb r~emaias a mystery
despite the vast and evertxpaadics researcb cAort (or . solution. Coo.ideries
their compleaNy, there should be no doubt that the aoswer, or amwer., wiY be
slow in comind asd will be b uod on discoveries by researchers is masy diecr-
tot disciplines.
The (acton o[ genetic makeup aad aging are important eoosiderasior is
the scientific effort to determine the puhoRenesis of these ailments. Aiso ies-
portaot are the recognition and examination of the impact m.de by the toul
environment of our iodustrialized society.
The areases and strairr of livinL exacerbated by worsening economic tww-
ditions and international crises, are being studied more closely for their porr
sibk role in body processes and d'ae..e accurretsce.
The overall situatioe, /rom a scicatiik viewpoint, is immensely ooesplen,
and one cannot expect a simple or easy solution. The Couocil, however, r.-
mains optimistic that answers wiN be found eventually; so too ar, other &raM-
ing agencies as well as aientists invdved in the research.
The Council believes that new ideas and fresh approaches to old but still good
ideas will continue to come from the world of scienee. l hat this is true ir aece
in the number of requests (or research aupport that The ('ouncjl receivea rc11u-
lariy. The ('ouncil remains dedicated to helping support independent isvesd-
gauas in their search (or definitive answers to eancer, heart disease and chroaic
pulmonary ailments.
7 he following section contains abstracts of research reports published
durins 1979 by rccipientc of Couqeil support.
7

Abstracts of Reports
Following are aburacts, approved by the autlwri, of reports on oenr
research acknowledging support /rom The Council that have appeared ie .cka
lifk journala since publication of the 1978 Report. The oame of tho recipket
ia in Nalics.
The abstracts are grouped under these headinp: 1. Cancer-Related Studie.,
11. The Respiratory System. 111. Ileart and Circulation. IV. Neuropharmacolory
and Physiob`y. V. phatmacolo6y and Biochemistry, V1. Immunology aod
Adaptive Mechanisms, VII. Epidemiology.
I. (;ancer-Re/ated S'tudIe.
BIOLOGICAL ACTIVf3Y OP TOBACCO SMOKE AND TOBACCO
SMOKE-RELATED CIIEMICAIS
There are three basic questions concerning the role of tobacco amoke IN
human cancer susceptibility: (1) Does tobacco amoke contain aubataooa that
interact with the microeomal munooayjenaset (2) I/ ao, what are some of Uw
in vivo and in vitro eflectsT (3) Are such eQecb more hmtdoua for urtais
individuals or tissues than for others? As ahows here, eaposure to w6ole cle-
ueue smoke Irom relerenee cigarettes promptly, but rather weakly, ioducea
murine pulmonary tnkro.amal matoosy6enase activity (peak activity at 6
hours; about 2-told). This can be detected with Ihe uae of benzo(a)pyrem or
ethoayresorulln as suburates, and is inhibited by cyclohesimide or actiaomycis
D. 7 hese smoke-induced incrcnes. Aowever, are not umequivocally linked to
the Ah locus as they are when caused by the Intratrache.l admini.uatioa of
3-methykholanthrene. Both whole amoke condenaa/e and its /ractiom ca.: (1)
induce pulmonary monoosygenase activity; (2) Mhibit btnto(a)pyrene metab-
olism in ritro; (3) be metabolized to subMances muta6enie to SdtnoweBa
typAl.nrrirm (TA133t or TA9e); (4) transform C311 IOT% oelb in vltro;
and (5) inlensi(y the carcinogenicity of benzo(a)pyrene ht murina lwsue. ro-
leatially important ia the observalion that while hepatic tis.ue has the capacity
to activale whole cigarette smoke condensate to mutagenic lorma !n v/t%
murine pulmonary Iiuue docs nut seem lo have Ihis capacity. Although murina
hutg homottenales posse.s slgnilkanl Allil activity and can metaboliae AAa-
toain 8,, 2aminolluorene and 7,tdihydro7,ldihydroaybenro(a)pyrena to mu
tagenic aubstances. they show only weak activity with the ptommutcn, 6-
aminochrysene and no activity with 2A1 cigarette smoke eoodeoaale. Macus-
sioa of these results centers on the concept that whole cigarette .moke may
be both a potential "iniliator" and it "ptomotor' of lung cancer in mice, and
on the notion that the lalter may be the most important determinant of cancer
risk.
Kouti, R. E. et d. (Alicro6iofoticd Auociatti) and flenrdict, W. F.
Environmentd Ilealth lertpertiver 29:6369, 1979.
From the neparament of Biochemical Onedo6Y, Microbiological Associatn,
Inc, Bethesda. Md., and Childtcn's 1lospital of Los AnIleks.
9

INHALATION BIOASSAY CHEMISTRY-WALTON HORIZONTAL
SMOKING MACHINE FOR INHAl.Al1ON EXPOSURE OF
RODEN fS TO CIOARETTE SMOKE
Until now, esperimenlal studies pertaining to tobacco smoke carcino-
genesis have been hampered by the lack of a convenient, readily vailabk and
wcll-deRned system capable of producing smoke for inhalation by (est animals
under standardized conditions. TM Wallon Horizontal Smoking Machine
( WIISM ), a commercially available derioa designed to expose as rnany as 20
mice to the smoke of a single citurtle, way provide the answer. Sfudies indi-
cate that this machine produces a uniform smoke aeroaol of predictable con-
centration with both high and low nicounctontent cigarettes. The aerosol's
composition was appropriate to both types of cigarettes: those with a high
nicotine conteot each delivered 40 mg total particulate ma/ler, 2 4 mE nico-
Iine, aml 17 cc carbon monoxide; thosa with a low nicotine cnnt:nl yielded
30 mg particulate matter, 0.3 mg nicoUna, and 17 cc carbon munoxide. For
this atudy, two diRerent qrains of mice. C378L and DBA/2Bd, were exposed
in the WNSM. In spite of limitations inherent to a system exposing animals
to standing smoke, the WHSM oQers the animal a uniform quaotity of smoke
whose concentration and composition (all within those predicted ky standard
analytical smoking. The period of exposure is characterized by a~kcrease in
the concenlrations of particulate matter aod asost gas phase constiwents, and
by an increase in particle size and carbon dioxide concentration in the exposure
chamber.
Guerin, M. ft. er al (Union Carbide)
Journal of the Nariona! Cancer lntrirWe 67(2) :411-41E, 1979.
OtAer.upport: U. S. Department of Energy.
From the Analytical Chemistry Division, Oak Ridge National Laboratory, Oak
Ridge, Tena_
ARYL HYDROCARBON NYDROXYLASE INDUCTION IN MITOGEN-
STIMULATED LYMPHOCYTES BY BEN2ANTIIRACENE OR
CIGARETTE TARS ADSORBED TO ASBESTOS FIBERS
Soma chemical and physical properties of amosile asbestos (AS) fibers
were examined here using Ihe human lymphocyte aryl hydrocarbon hydroi-
ylase (AHt1) enzyme system as an inveqigative tool. When cultures of mito-
gen-stimulaled lymphocytes were Incubated with AS, an increase in Atilt
activity was noted. A much grealer increase in enzyme aclivrty followed addi-
lion of the inducen benzanthracene (BA) or cigarette lars (CI ) to cell cut-
tures. Significant enzyme induction also occurred when AS fibers were 8rst
preincubaled with CT or BA, washed with acetone, then added to lymphocyte
cultures. lhis increase in Atilt activity was not as great, however, as the in-
durliun uMervcd when BA or CT was added to cell cultures. Overall, the
cnrynsc .clr.rly in cells rncubated with (T preuealeJ AS par/rcks was not as
Rrs.r .% she aar...ry in ('1 rnJrrceJ IyrnpMrcyres ur nr lymphrnyla 14- whrah
t 1u.l \\ ,.crr .u..ulr.nc.ruslr aJJeJ Ihese rc.ulls mJrC.le 1h./ puly:yclie
a ru.ru hsc6- %.sh .. NA .nJ cumirrnrnl% ui ( 1, cau Ire ad.urhed
i
to AS parlicka, which then function as carriers for the transport of these com-
pounds into cells.
McLemore, T. L., Jenkina, W. T., Arnorr, M. S., and Wray. N. P.
Canrir Lerrerr 7(2,3):171-177, 1979.
Other lupporer Veterans Administration Hospital.
From the Veterans Administration Hospital; Departmcnt of Biology. "ibe Uai-
versity of Texas System Cancer Center; M.D. Anderson Hospital and Tunar
Ins1i1u1e, and the Dep.rtment of Medicine, Baylor College of Medicina,
Ilouston.
INDUCTION OF ARYL HYDROCARBON HYDROXYI.ASE IN HUMAN
PERIPIIERAI. BLOOD LYMPH(X:Y7E3 BY CIIRYSENE
Many polycyclic aromalk hydrourbons (PAIIa) Induce aryl hydrocarbon
hydroxylase (AIIH) in human lisasres. This report describes the rok of chrys-
ene-an environmental contaminant formed aa a result of the pyrocondeaaa-
tioa of various cornpounds, including tobacco products-as an inducer of
AHH in human lymphocytes in vitro. Lymphocytes obtained (rom healthy
human subjects were cultured for tl hours, then incubated with chrysene i.
rcetone for an additional 24 hours. The chrysene-induced cella showed a aill-
nifkant increase in cnzyme induction when compared to controls incubated
with acetone alone. Preliminary observations suggest that the time course (or
chrysene induction of Atilt is similar to that of benzanthracene (BA) and
7-nxlhykholanthrene (3-MC) induclion, the maximum being reached linearly
after 24 hours of incubation. Other s/udin with pregnant rats suggest that
chrysene also increases AHH activity !w r,iro. Tirc present study, moreo.er,
indicates inlerindividuat variation in ANN inductibility with ehryaene, but
this is commensurate with that obtained with SA or 3-MC. While there Is a
theoretical relationship between Atilt induction and chemical earciaoRenesis,
the connection between carcinogen metabolism and cancer susceptibility is
man has not been established. Consequently, reports wch as these might help
to determine the role of enzyme induction in Iha susceptibilily to diaease caused
by exogenous agents. Although Ihe meubolilea of chrysene produced by At1Fl
are only weak carcinogns. the abundance of this hydrocarbon ia cigarette
smoke might have an idirect but significant rok in the amplifkaliow of the
Atilt system in the lungs of cigarette unokers.
Snodgrass. D. R., Mcl.emore, T. 1.., Marshall, M. V., Wray. N. P. Cantrell.
E. T., Busbee, (). 1.., and Arnar, M. S. (MarNw, R. R.)
Cancer [.erters 7 : )1)-)1 e, 1979.
Other .o'portr lhe Welch Foundation, Nalional Institutes of Health, Amer-
ican Cancer Society, and the Veterans Administration Hospital, HouMon.
From the Department of Biological Sciences, North Texas Slate University.
Denton; [kpanment of Pharmacology, Teaas College of Oaleopathic Medicine,
For/ Worth; /kpartmenl of Environmental Biology. l)nivenity of Tesas, M D.
Anderson Hosprul and Tumor Institute; (kpanment of Medicine, Baylor
C'olkge of Medicine; and Veterans Administration Ilospilal, Houston.
11
10

INDUCf1ON, INIIIBITION, AND SOME ENZYMOLOGICAL
PROPI:RTIFS OF ARYI. IIYDKO('ARBON HYDROXYLASE IN
FRL'SII MITOGEN-AClIVAT1:D HUMAN LYMPHOCYTES
This report describes the induction and Inhibition speciflcities and some
other enrymologic properties of lymphocytic aryl hydrocarbon hydroaylase
(AHHI Basal and/or polycyclic hydrocarbon (PAII)-induced AlitJ in mito-
ten-activated cultured lymphocytes from healthy donors were used to study
these properties. Several compousds with an Inducibility ralio > 2.0 were
found among the 24 chemicab lested: 2,I,7,S-telracMorodibenzo-o-dioain
(TCDD), dibenz(a,li)anlhracene (D<!A), benz(e)anthracene, 7-methykhot-
anthrene, P -naphthoflavone, chokcakiltrol, and tx.-isoproterenol. The Rrs1
four, Iisled in descending order of potency, were Ihe mwt vigorous inducen.
lhcse appear to activate the common penelitally determined factors involved
in Alllt induction, suggesting that they could be used Inlerchanlieably. EAects
ranging from inhibition to mild inducliorr were obtained with other substances:
1-bromoffavone, .-naphthofiavont, chrysene, p.,*-1,1,1-Irichbro-2,2-bis ( p<hloro-
phenyl)elhane, 7,12dimelhylbewnthrateee, pyrene, o,z-norepinephrine,
bcnzo(r)pyrene, lindane, n octylamine, Ie.toueroee, 2.3diphenybsar.ok,
170estradiol, mclyrapone, and phenobarbital. The inhibilon were ranked In
descending order of potency as follows: mr-napMhoflavone, p-naphlloflavone,
2dielhylanainoe/hyl-2,2-diphenylvakrak, nsetyrapone, 1,1,1-Iricholoropropene
oaide, and cyclohesene ozide. Depending on their concentratioe, the Iaa1 four
produced moderate inhibition to moderate stimulation. However, the inhibitioe
pattern for the basal and the PAH-induced AIIH was Indistirguishabk. Both
the half-life of the enzyme during cell culture and the K. values of A/IH in
uninduceJ and PAII-induced cells were similar as well. Based on this and other
evidence, it can be concluded that: (1) 'ICDD. DBA, benz(.)anlhracene, and
.l-methykholanlhrene have a common mechanism of action whereby only the
degree of AHH induction produced dt8ers; and (2) basal and induced AHII
are qualitatively similar and only quantitatively different in comparabk unin-
duced and PAH-induced cells.
Gurtoo. H. L. ct ol.
Cancrr RrsrarcA )9(11) :1620-1629, 1979.
Other aupp.rtr National Cancer Institute.
From the Departments of Eaperimental Therapeutics. Molecular BirJoty. and
Immunobpr, Roswell Park Memorial Institute. New York Slale Department
of I/ealth, suflalo.
ARY1. HYDR(X'ARBON HYDROXYLASL' IN A STABLE HUMAN
B I.YMPII()CYl F. ('EI.I. LINN, RPMI-17H0, CUL7URED IN TIIE
ABSENCE OF MI t(X3ENS
K/'M1 170e is an imorunoRlnhulin synlhesiring B-lymphncyle cell line
that has shown hish basa and indrKrbk aryl hydrocarbon hydroaylasc (/1/11t)
at tivily in the ab.rne c rtl nutuRcmc preslimulation Durin6 the course of the
c.l,~nruts ir/NUi.J hrec. .ri,aut p.ramcters influcncmg the enzyme activity
i
and inducibilily were studied and optimized. This allowed altlainmeett of
enzyme levels and inducibility ratios comparable to those previously reported
for fresh milosen-aclivaled human lymphocytes. However. Ihio cell line haa
several advantages over fresh lymphocytes: (a) high AIIlI aclivNy in the
absence of milogen preslimulation; (b) availability in unlimited quantities le
the absence of donors; and (c) the consistency gained by using a ain6le huma.
cell line free from seasonal variation of donors. It'seems, therefore, that this
system could provide a good esperimental tool for studies on human mised-
tunction osygenases. In addition, using cells cultured under oplimal,conditions
and induced optimally with dibeoz(.,h)anahraccne. the melabolisrn of bee-
zo(a)-pyrene was analyzed by high-pressure liquid chromatography. The
melabolile profik produced by these cells had severd similarities with Ihosa
produced by mitogen-uimulated, abort-term cultured human lymphocytes de-
rived from fresh blood.
Freedman, 11. 1., Gwroo, Il. L.. Mieowada, l., PalSee. S., and Vaught, l. 0.
Cwscrr RerearcA )9(11) :1605-1611, 1979. '
Other.rpportr National Cancer Institute.
Front the Departments of Eaperimenlal Therapeulics, Molecular Sioloq aed
Immunology, Roswell Park Mernorial Instilute, New York State Department of
Health, Buffalo.
INDUCTION, INIIISITION, AND eIOLOOICAL PROPERTIES OP ARYL
HYDROCARBON HYDROXYLASE IN A STABLE HUMAN
B-LYMPHOCYTE CELL LINE. RPMI-178t
The present paper reports on the ieductbn ud Inhibition by .atious
chemicals of aryl hydrocarbon hydrosylaae (AHH) iw a slabk, imnwteolog.
kally de6ned (ISM-yiek/ing) S-lymphocyle line (RPMI17llU), as well aa ae
the kinetic and biological properties of the ewzyme In these cells. This pr-
ticular line had previously beee selected as a biochemical ruodel for AHII
.ludies mainly because of Its hi6h enzyme activity ie the absence of mitopeos.
In the dose ranges tested and on a molar baia, the inducers, in deaoeodie6
order of polency, were: 2,),7,!-telrachlorodibenzo-p-diotin, dibenz(.,A)aa-
thracene (DBA), l-methykholanthrene, benzo(.)pyrene, and 1,2-beezanthra-
cene. Included among the potemial inducers that paradoaically lowered basal
AIIlI, were 7,12-dimethylbenzan(hracene, 2,Shcphenylosazok, and chryacee.
Under optimal culture curdilions, induc/ion promoted maaimum enzyme activ-
itics three- to four-fotd that of batal AIIH. lYm characterhllcs of the 1)sA-In-
duced and basal enzymes were virtually idenikal. lhe pat curves were similar
for brMh (R.23 optimum), as was inhibilor specificity. Induced and basal
enzymes displayed similar half-lives, apparent activation encrgies, optimal tem-
peratures. denaturation temperature range, end apparent Kr with benzo(.)
pyrene. lhe small differences observed in Ihe latter were related to the enzyme
concentratarn during incubaion rather )han to its yuai/y.
Freedman. 11. 1., Parker, N. 8,, Marinello. A. 1., (irrroo, 11. l.. and Mino-
wada, 1.
1)
12

Cancer Rerrarch )9:4612-4619, 1979.
Ottier.upportt National Cancer Itatitute.
Prom the Departments of Experimental Thenpeutia and Immunology. Roswell
Park Memorial Institute, New York State Department of 1(ealth, Buf(ab.
CELL SOR i'ER ANALYSIS OF CARCINOGEN METABOLITES IN
HUMAN 71SSUES
The biochemkal parameters of a betesv~eoaw culture of human (ympho-
cytes were eaamined with a f)sortsoeeoe-activated ceN sorler (FACS-11).
During culture, the cells were incubaled i. the presence of benz(a)an:hracene
(BA) to induce the enzyme system that metabolizes carcinogens. Direct assay
of carcinogen metabolism was achieved by measuring the phenolic meubolites
of cells e.posed to benso(a)pyrene (BP). According to single cell measure-
ments. BP metabolism was grealer in tbe larser cells than in Ihe smaller ones.
In the cells exposed to BA during cultura, the entyme aclivity also was greater
(or a given cell size. In some of the studiea, dabk celb were Ont sorted out
sccordind to size nd the wbpopulations were tusayed (or the o-deethylation
of eihosyresorufln, a compound that measures eylochrome P-44E1 activ:ty more
specifically. In corroboration with the direct metuuremenu, the larger cells
demonstrated higher en:yme activity levels thas 1he smaller ones. The technique
of sorting before enzyme assay. as described here, can be applied to other
tiswes, as well as to other cell types asd enzyme systems that cannot otherwise
be measured directly.
Tyrer, lf. W., Adams, L. A.. Tdlany, S. M., O'Connell. J. P., and Cantrei(, E. T.
The /ownd of !llytocheminry and Cytochemirtry 27(1) 30N-S 11, 1979.
From the Becton, Dickinson Research Center. Research Triangle Park. North
Carolina; Tesas College of Osleopathic Medicine. Fort Worth; and Division
of Cytopslhdop, 1)epartment of Pathobp, The Johns Hopkins University
School of Medicine, Baltimore.
ACTIVITIES OF POLYCYCLIC HYDROCARBON ACTIVATING AND
INACTIVATINO ENZYMES IN HUMAN LUNGS OF SMOKF.RS,
NON-SMOKERS, LUNGCANCER AND NON~CANCER PATIENiS
Polycydk hydrocarbons (PAH), which are present everywhere, eaert
lheir adverse effects only afler metabolic activation. The mkrowmnl nwno-
o,ygtnase system (MO) catalyses tM osidaliw biotrans(ormation of asreat
number of endo6enous and exogenous compounds and ia also rtsponstbk for
the formation of eiectrophilically reactive eposides from PAII. Concentrations
within the ceUs of Ihese reactive epo.idet, which are suspected ultimate car-
cinoRens, may be conerolkd no1 only by the MO aclivitits, but alur by the
eposrdemetabuli:ing epoaide bydratase (PH) and tlutalhione-Suarrs(erase
((iF) ectivilies. Since such dats did not seem to eaisl, the epoaide (orming
and metaboli:ind enzyme activities were meuured in 47 ssmpks from lunp
of smukers, nonsri>,.\ers, lung cancer and noneaneer patients and correlated to
the rMcurnence rd e.ncer When uand.rd assays were used, no Ml) activity
.uulJ f.r dcte.ted m hun..n lunp, alth.>,t6h the very setadrve assays with
ben:o(a)pyrene, 7<thoaycoumariq 7-etboayreaoru(in and biphenyl as wtb.
strates were used. However, these activities in rat lung mkrosornes used as
positive controls were always clearly meawrabk. By ooincub.tios of ral lueg
microsomes with human hms microsomes, It could be demorulrated 16at 7-
etho.ycoumarin-odedhyl..e activity wu inhsbiled by the presence of hurn.n
lung microsomes after preiacubation for 13 minutes. 'Ibes. Bndinp wyeM
the presence of diffusible inhibitor is human hmR microoaees. 1. 16e
enzyme activities of human lung aampks, considerable i.lerindi.idwl va,riiatioas
were observed. However, no sisa(kant diRereuces (P>0.1) were found wbes
enzyme activities in IunRs from notscsaeer patients awd .oa.rnoken ww
compared with thow from lung cancer p.lie.ts, suggesting Wy other (acfors
may affect differences is lung tumor wuceplibility.
Lorens, 1., Schm.asmann, H.. Ohnhaw, E. and OercA, F.
Archlver of Toairofoq. Suppl. 2(Meehanitrn of Toxic Action on Soene Tarpt
Orpns) :4l1-4l9, 1979.
From the Section on Biochemical Plurm.eobQr, Institute of Phann.oo{ogy.
University of Main:, Main:, Wes1 Germawy; a.d Inaelspitd Bers, Switzerland.
A NEW ASSAY FOR GLUTATHIONE S-TBANSFERASE USINO (H)-
BENZO(A)PYRENE 4,S-OXID6 AS SUBSTRATE. INDUCIBI(.ITY BY
VARIOUS CHEMICALS IN DIFFERENT RAT TISSUES COMPARED
TO THAT OF ARYL HYDROCARBON HYDROXYLASE AND
EPOXIDE HYDRATASE
A new assay for glutathione S-tratuferass that uaa (s11)-benrp(a)pysw.
4.5-oxide as a substrate Is described. Compared to previously propo.eA net6ob.
this assay offers several adoantapes: (1) it ia easily .od rapidly per(orsnea,
requiring only one extraction step and eliminating the usual chromatorphic
sep.ratioa of substrate and products; (2) it tNilires as a substrate am s ids
metabolically produced from a ea(einodetsie polycyelie aromatic hydrocarbon;
and (3) it is performed under optimum conditions for the pll and eo.oes-
trations of the two substrates (ghNalhione and epoaide). This assay wr used
1o study the effect on Shnathione S-transferase of compourds kt.ows w induce
drug metabolizing enzymes. The activity of gIWathions Stransfetase was oaly
slightly aflected by varioua inducers. In this respe.ct, it ia very diRerent from
other enzymes inswlved in polycyclic hydrocarbon metabolism: liver epoalde
hydralase was very sianifkanty enhanced by phenobarbilal and 16tyaoo-
pregnerwrlon. Iwatmenl, and aryl hydrocarbon hydrosylasa appeared to be
very easily arnd strongly induced (n many wgans by several chemkals. 'Ihese
results further support the eoMention that in contrast to other en:yaw,
glutathione S-transferase itduetion probably has only a minor role in the
regulation of polycyclic arumalic hydrocarbons elwninalion.
Van ('anlfort, I.. ManU, 1.., (ikkn, I. E.. (Ball, 11. R., aad UcrcA, F.
Biochemical Pharmacology 2(1(4 ):4S S460, 1979.
From the I ahoratoire dc ('himk MEdicak, Imtitul de Palholugic, San Tdmaa
par I itae, Nelsium; and the Section on BNrchemKal Pharmacolo6y, Institute
of Pharnsacology. Universtty of Mainr, Mainr, Wcst ('.ermany.
14 I'S

i
i
{
RI:Dl1C1lUN OF t11:NZO(a)PYRENE MUTAGt:NICITY BY
DIIIYDRODIOL UEHYDRO(iENASti
Since epoaide hydratase cannot inactivate the dihydrodiol epoaides pro-
duced by the environmental carcira8en, benzo(a)pyrerse, the abiLty of a
dihydrodiol dehydro8enase to sequester the precursor dihydrodioh an,' thereby
to aflord protection from the later, more reaclive, dihydrodiol ept..iIcs was
investigated. To carry out this study, a purified form of the enzyme had
to be prepared. The effect of pure dihydrodiol dchydro8enase on llse mula-
Senicity of bento(n)pyrene was then studied in the microsomc/Salnwnclla
lest. Here two metabolic pathways mainly contribule to the muts8enicily of
benro(a)py'ene: (1) activation to bento(a)p)rene-,,s-oaide and (2) drhydro-
d'wl epoaides. ihe Salnwnrlla rypAlnrrrlvrw arains TA 98 or TA 1110 are
highly susceptible to bulh Sroup" of muta8enie wrelabuliles, whcrea Iisc strain
lA 15)7 is much mote susceptible Io the 1,l-oside than to the drhyQrodnA
epoaidts. Results showed that when benzo(a)pyreno was activated by liver
microsomes from 3 nselhylcholanthrene-trealed mice, addition of pure dihy-
drodiul dehydrogenase ekarly reduced the reula8enicily. The effect increased
with the duse up to 0.5 units per plate; (urther addition of dihydnAiul de-
hydro8enase had no si8nifkant effect. The percentage of the bcn:ol.)pyrene
mutarcnicrty which could be removed by dihydrodiol dehydro8enase depended
oo the bacterisl strain. With 1A 98, it was 30-609i, and with TA IS37, as
eapecled from the lower sensitivity of this strain (ot benzo(e)pyrerse drhydro-
dio) eposides, it was smaller. lhus, it was concluded that dihydrodiol de-
hydru8enase can protect atainsl muu8enie effects ol benzo(a)pyrene, but
that not all the mula8cnic mcuhuhtcs ul bttuo(a)pyrene esn be rensuved by
lhis enzyme. Howevcr, the mutagemctty mediated by the drhydrodiu6epuaide
pathway opens an intriguing perspecttve for the entire field of polycyclic
hydroearbontvoted muls8enicity, carano8enicity and cyloloaicity.
(11a11, II. R., Vogel. K., Bentley. P., and Orsch, F.
Naturr 277:319-320, 1979.
From the Section on Biochemical Pharmacology. Institute of Pharmacolop.
University of Mainz, Maioz, West Getmany.
MUTAGENICI TY TFSiING OF NITROGENOUS COMPOUNDS AND
1H1iIR N-OXIDIZt:D PRODU('iS USING TRP+ IN E. COU
The N-oaidalion of certain aromatk amirses, aromatic ansiJcs and
carbamates can produce mula8enic and carcinogenic compounds. Consequenlly,
the development of short-term tests designed lo evaluate potential nsYs front
new compounds is highly desirable. lhis report describes a spot test ut:lizin8
tryM"phan ( Trp t) reversion In E. coli to detect substances that cause Aase-pair
substitWion, a measure of mula8enicity. A variety of nitro8entontainin8
compoundi and their chemically synthesized N-oxidation products was es-
amined 1 be N oarnlalion of certain aromatic amines and earb+malcs was
assuaiatcd with mutagenic aclivrly, bul that of aliphalie amincs, tertiary sro-
matrc annnes. helrnMyclic numrtic amines, and aromalic aosides did nu1 yicld
pnMlutts srl;nificandy nwre nnwagcnic than the parent cumprwnds.
16
I
i
t
Pai, V., Bloomfkkl, S. F., lonca, l. and Gorro/, !. W.
In: Gorrod, l. W. (ed.): siiolosird Otidatlow o/ Nlnotew. New Yortt:
Elsevier/North-Holland Biomedical Press, 1978, pp. 375-382.
From the Department of Pharmacy, Chelsea College. Univenity of l.ondon,
Londoo.
TIIE IN-VIVO N-0XIDATION OF 3-SUBSTITUTED PYRIDINES
FOt.1.OWING 111E1R INTRAPERITONE'AL ADMINISTRATION
Previous Mudin have shown that several 3-subslitutcd pyridina ara
oaidired /n rlno al the pyridyl nilro8e.. ihe in rlro meubulism of pyridiae
and of its lchkxo and 3-methyl derivatives was therefore resaamined Is
order to determine the role of N-oaidation In the metabolism of these com-
pounds. Following the intraperitoneal admi.istralion of thc parent pyridina,
pyridine-Noaide, )-methylpyriditse-N-oaide and 3<hloropyridine-N-oside were
detected in the urine of mice, hamslen, rNS. Suinea pip, rabbils, and fcrrcu.
N-oaidalion proved to be a quantitatively Important metabolic pathway /or
pyridine. The urinary eacrelion of the N-oaide ranged from about 10% o/ the
dose adnsinistered in ra/s to about 40% In mice and Suinea pip. With
3chbropyridine and 3-melhylpyridine, the N-oaides accounted for kss Ihan
seven % of the administered dose. Mice prelrealed with phersobarbitnne showed
increased urinary levels of pyridinc-N-oaide, but 3-nrcthykholanthrene pro-
treatment had no noticeable eRect.
Damani, 1.. A., Disky, L. 0. and Gorrod, J. W.
In: Gorrod, l. W. (ed): eidorkal Oa/datlon o/ Nluotew; New YorT:
t:lsevier/North-Ilolland Biornedical Press, 1978, pp. 157-162.
From Ihe Deparlment of Pharmacy, Chelsea CoqeBe, University of l.oedo.,
Londas.
SOME FACTORS INVOLVED IN THE N-OXIDATION OF 3.
SIIBSTfI UTt:D PYRIDINES BY MICROSOMAL PREPARKiIONS
IN Vf7'RO
While the uaidalion of nkrNinamide to the N osWe has been demon-
slratcd ln r/tro. the N-osidaliun of the pyridyl nitrogen in various drup and
c.Hnpounds with this type of amine function has not yet been studied ea-
tensively, either in rirro or its riro. There/ore, in order to establish the
occurrence of pyridine-N-usidatiun and to establish the en:ymolo8y of Ihe
various reactions invulved, a systematic study of hetero-arornatie N-osidation
was begun with the use of a series of 3substituted pyridines as ns.Klet com-
pounds. It has prevronsly been shown that oaidation at the pyridyl nitrogen
appears to be a Ecncral melalxslie In virro routc /ur several 3-substiluted
pyrwlines. lhc elkcts of various factors on the C- and Noaidation of 3-melhyl-
17
